Paying for personalized care: Cancer biomarkers and comparative effectiveness

► Effective personalized therapies are being introduced rapidly. ► High costs can make these therapies prohibitive. ► Genomic based diagnostics can direct these therapies effectively. ► Diagnostic value depends on health outcomes, logistics, and resources utilized. ► Comparative effectiveness provides valuable tools for assessing diagnostic value.